Feb 23, 2024 Discussion: Off-Label Drug Use
Discussion: Off-Label Drug Use
A Sample Answer For the Assignment: Discussion: Off-Label Drug Use
Off-label drug use among children is when prescription medications are used to treat conditions not approved for use by the Food and Drug Administration; this practice is widespread; nearly half of the drugs prescribed to kids are used off-label (Meng et al., 2022; Allen et al., 2018). However, its safety and effectiveness remain highly controversial.This paper addresses specific instances when children should receive off-label use drugs as well as strategies that make this practice safer for infants to adolescents.
Circumstances for Prescribe Drugs for Off-Label Use in Children
Children may sometimes require off-label drugs to treat certain conditions effectively. A good example of this is the use of Fluoxetine for OCD, even though the FDA has not approved them for treatment of this disorder (Shuib et al., 2021). Antipsychotic medication could also prove helpful against severe behavioral problems associated with Autism or ADHD, even though only intended for adult treatment.
Off-label drugs may also be prescribed when there are no approved treatments available to pediatric patients; such as when cancer drugs approved by adult medicine have not been studied on children who also suffer from that form of cancer; healthcare providers must carefully weigh potential risks against benefits to ensure that any medication prescribed meets all standards in terms of patient safety and satisfaction.
Strategies for Safer Off-Label Use in Children
Various approaches should be employed when prescribing off-label drugs to children to ensure their safety and efficacy. One strategy involves closely tracking a patient’s medication response and making appropriate dosage changes (Meng, Zhou, et al., 2022). Another strategy might involve pairing the drug with additional therapies like behavioral or psychotherapy sessions for optimal effectiveness and reducing the prescribed dose. Finally, healthcare providers must factor in age, weight and overall health status when prescribing an individualized dosage schedule for every child they treat.
Struggling to Meet Your Deadline?
Get your assignment on Discussion: Off-Label Drug Use done on time by medical experts. Don’t wait – ORDER NOW!
Meet my deadline
Discussion: Off-Label Drug Use
Healthcare providers must exercise extreme care when prescribing off-label drugs to pediatric patients. Opioids like codeine and tramadol that could potentially cause respiratory depression in young children must only be prescribed with consultation from healthcare professionals beforehand, while antibiotics such as tetracyclines have the potential of discoloring tooth enamel; all must be considered carefully to ensure safe and effective off-label drug usage among pediatric patients (Meng, Zhou, et al., 2022). By considering such factors, healthcare providers can ensure the safe and effective usage of off-label medicines among pediatric patients.
Conclusion
Off-label drug usage by children remains a controversial subject. They may be necessary in certain instances; however, when making this decision it should be approached carefully. While limited research exists regarding their safety and efficacy in kids, this might be their only treatment option in certain instances. Healthcare providers must carefully weigh the potential risks and benefits of off-label drug usage among children before prescribing.
When administering off-label medicines to kids, various strategies can be employed to safeguard safety and efficacy. One strategy involves closely tracking how well patients react to the medication and making any necessary dosage adjustments accordingly. Another tactic involves using medication alongside behavioral or psychotherapeutic therapies as complementary measures. When determining an ideal dosage regimen, healthcare providers should also factor in the child’s age, weight, and health status.
Being essential in expanding the evidence base and safety when prescribing off-label medicines to children. As research progresses, it is paramount that healthcare practitioners remain diligent in assuring the safe and effective use of off-label medications within pediatric populations.
References
Allen, H. C., Garbe, M. C., Lees, J., Aziz, N., Chaaban, H., Miller, J. L., Johnson, P., & DeLeon, S. (2018). Off-label medication use in children, more common than we think: A systematic review of the literature. The Journal of the Oklahoma State Medical Association, 111(8), 776–783.
Meng, M., Lv, M., Wang, L., Yang, B., Jiao, P., Lei, W., Lan, H., Shen, Q., Luo, X., Zhou, Q., Yu, X., Xun, Y., Lei, R., Hou, T., Chen, Y., & Li, Q. (2022). Off-label use of drugs in pediatrics: a scoping review. European Journal of Pediatrics, 181(9), 3259–3269. https://doi.org/10.1007/s00431-022-04515-7
Meng, M., Zhou, Q., Lei, W., Tian, M., Wang, P., Liu, Y., Sun, Y., Chen, Y., & Li, Q. (2022). Recommendations on off-label drug use in pediatric guidelines. Frontiers in Pharmacology, 13, 892574. https://doi.org/10.3389/fphar.2022.892574
Shuib, W., Wu, X.-Y., & Xiao, F. (2021). Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review. World Journal of Pediatrics: WJP, 17(4), 341–354. https://doi.org/10.1007/s12519-021-00430-3
Situations When Off Label Medications May be Used in Pediatrics
There are specific situations when medications in the regard of off-label medications can be given to children. For instance, whenever a drug which is meant to manage a particular condition has been used without demonstrable success, a physician can choose a different alternative to save the day (“Off-Label use of Medicines in Children,” n.d.). A physician may be compelled to prescribe a drug to a pediatric when a particular formulation is available in a different country in another possible scenario.
Yet there are acute shortages in their areas of jurisdiction. On the other hand, the physician can make an importation request for a drug used in another country for adults but for children in their country (Allen et al., 2018). Examples of the off-label medications used in children include amoxicillin, used for different conditions, including otitis media. There are specific medications which are high risk and should be used with caution in paediatrics, including dopamine, hydromorphone, oxycodone and lorazepam (Czaja et al., 2015). The medication could cause pronounced psychological effects or even unforeseen death.
Strategies for Off-label Medications for Pediatrics
Whenever off-label medications are used in children, there ought to be strategies to ensure they attain the best possible outcomes with minimal adverse effects. More clinical trials should be considered but within the safety and ethical parameters in children to establish the efficacy of medications (Tefera et al., 2017). The healthcare providers, the nurses, physicians and pharmacists should have efficient reporting methods and address the occurrence of adverse effects in children, which would then enhance the use of the medications.
References
Allen, H. C., Garbe, M. C., Lees, J., Aziz, N., Chaaban, H., Miller, J. L., … DeLeon, S. (2018). Off-Label Medication use in Children, More Common than We Think: A Systematic Review of the Literature. The Journal of the Oklahoma State Medical Association, 111(8), 776–783. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/31379392
Czaja, A. S., Reiter, P. D., Schultz, M. L., & Valuck, R. J. (2015). Patterns of off-label prescribing in the pediatric intensive care unit and prioritizing future research. Journal of Pediatric Pharmacology and Therapeutics, 20(3), 186–196. https://doi.org/10.5863/1551-6776-20.3.186
OFF-LABEL USE OF MEDICINES IN CHILDREN | INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH. (n.d.). Retrieved February 2, 2021, from https://ijpsr.com/bft-article/off-label-use-of-medicines-in-children/?view=fulltext
Tefera, Y. G., Gebresillassie, B. M., Mekuria, A. B., Abebe, T. B., Erku, D. A., Seid, N., & Beshir, H. B. (2017). Off-label drug use in hospitalized children: A prospective observational study at gondar university referral hospital, northwestern Ethiopia. Pharmacology Research and Perspectives, 5(2), 304. https://doi.org/10.1002/prp2.304
Permalink: https://nursingmasters.blog/discussion-off-l…se-in-pediatrics/
Discussion: Off-Label Drug Use in Pediatrics
The unapproved use of approved drugs, also called off-label use, with children is quite common. This is because pediatric dosage guidelines are typically unavailable since very few drugs have been specifically researched and tested with children.
When treating children, prescribers often adjust dosages approved for adults to accommodate a child’s weight. However, children are not just “smaller” adults. Adults and children process and respond to drugs differently in their absorption, distribution, metabolism, and excretion. Children even respond differently during stages from infancy to adolescence. This poses potential safety concerns when prescribing drugs to pediatric patients. As an advanced practice nurse, you have to be aware of safety implications of the off-label use of drugs with this patient group.
To prepare:
· Review the Bazzano et al. and Mayhew articles in the Learning Resources. Reflect on situations in which children should be prescribed drugs for off-label use.
· Think about strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Consider specific off-label drugs that you think require extra care and attention when used in pediatrics.
With these thoughts in mind:
Post an explanation of circumstances under which children should be prescribed drugs for off-label use. Then, describe strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Include descriptions and names of off-label drugs that require extra care and attention when used in pediatrics.
This work should have Introduction and conclusion
– This work should have at 3 to 5current references (Year 2012 and up)
– Use at least 2 references from class Learning Resources
The following Resources are not acceptable:
1. Wikipedia
2. Cdc.gov- nonhealthcare professionals section
3. Webmd.com
4. Mayoclinic.com
Required Readings
Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Ambler, PA: Lippincott Williams & Wilkins.
Review Chapter 4, “Principles of Pharmacotherapy in Pediatrics” (pp. 53-63)This chapter explores concepts relating to drug selection, administration, and interaction for pediatric patients. It also compares age-related pharmacokinetic differences in children and adults.
Chapter 17, “Ophthalmic Disorders” (pp. 221-243)This chapter examines the causes, pathophysiology, diagnostic criteria, and drug treatment for four ophthalmic disorders: blepharitis, conjunctivitis, keratoconjunctivitis sicca, and glaucoma. It also explores methods of monitoring patient response to treatment.
Chapter 43, “Attention-Deficit/Hyperactivity Disorder” (pp. 743-756)This chapter explains the process of diagnosing Attention-Deficit/Hyperactivity Disorder (ADHD). It also identifies drugs for treating patients with ADHD, including proper dosages, selected adverse events, and special considerations for each drug.
Chapter 51, “Immunizations” (pp. 906-926)This chapter explores vaccines that are licensed for use in the United States and provides a recommended vaccination schedule for pediatric patients and adults.
Chapter 52, “Smoking Cessation” (pp. 927-943)This chapter examines clinical implications of smoking. It also covers various approaches for aiding patients who are dependent on nicotine but want to stop smoking.
Chapter 54, “Weight Loss” (pp. 945-956)This chapter begins by reviewing patient factors that contribute to obesity. It also examines drug therapy for initiating weight loss in patients, as well as alternative non-drug treatments.
Bazzano, A. T, Mangione-Smith, R., Schonlau, M., Suttorp, M. J., & Brook, R. H. (2009). Off-label prescribing to children in the United States outpatient setting. Academic Pediatrics, 9(2), 81–88.
This study examines the frequency of off-label prescribing to children and explores factors that impact off-label prescribing.
Mayhew, M. (2009). Off-label prescribing. The Journal for Nurse Practitioners, 5(2), 122–123.
This article reviews the prevalence of off-label prescribing, including its benefits and risks. It also explores issues regarding the safety of off-label prescribing and when it is unavoidable.
Drugs.com. (2012). Retrieved from http://www.drugs.com/
This website presents a comprehensive review of prescription and over-the-counter drugs including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.
Required Media
Laureate Education, Inc. (Executive Producer). (2012). Advanced pharmacology – Final course review. Baltimore, MD: Author.
This media is an interactive final review covering course content.
Order a similar assignment, and have writers from our team of experts write it for you, guaranteeing you an A
